英科医疗
(300677)
| 流通市值：165.78亿 | | | 总市值：233.49亿 |
| 流通股本：4.65亿 | | | 总股本：6.55亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 2,493,933,645.56 | 9,523,317,123.49 | 7,098,445,816 | 4,512,068,808 |
| 营业收入 | 2,493,933,645.56 | 9,523,317,123.49 | 7,098,445,816 | 4,512,068,808 |
| 二、营业总成本 | 2,227,922,943.92 | 8,106,201,641.65 | 6,392,765,528 | 3,933,662,122 |
| 营业成本 | 1,891,377,146.12 | 7,272,347,663.47 | 5,506,101,002 | 3,524,050,602 |
| 税金及附加 | 28,621,027.7 | 65,551,156.4 | 46,960,301 | 31,266,713 |
| 销售费用 | 71,185,277.78 | 288,443,843.68 | 202,654,119 | 136,642,867 |
| 管理费用 | 149,369,194.14 | 518,139,926.38 | 378,905,763 | 248,389,458 |
| 研发费用 | 99,551,616.56 | 398,344,414.56 | 293,282,144 | 189,422,159 |
| 财务费用 | -12,181,318.38 | -436,625,362.84 | -35,137,801 | -196,109,677 |
| 其中:利息费用 | 95,394,054.88 | 308,037,023.74 | 207,733,594 | 129,615,392 |
| 其中:利息收入 | 131,053,333.02 | 533,356,405.99 | 389,245,660 | 257,968,484 |
| 加:公允价值变动收益 | 72,441,131.1 | 279,767,035.6 | 32,357,675 | 65,360,021 |
| 加:投资收益 | 24,266,443.12 | 63,176,605.34 | 49,350,964 | 46,141,068 |
| 资产处置收益 | -16,469.02 | 224,360.4 | 15,891 | 15,891 |
| 资产减值损失(新) | -953,122.65 | -109,052,505.2 | -1,610,083 | -9,607,766 |
| 信用减值损失(新) | 1,492,874.31 | -32,779,876.77 | -34,707,611 | -28,283,147 |
| 其他收益 | 33,524,964.94 | 58,372,443.32 | 34,765,544 | 16,021,551 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 396,766,523.44 | 1,676,823,544.53 | 785,852,668 | 668,054,304 |
| 加:营业外收入 | 588,408.76 | 2,541,261.33 | 5,032,460 | 4,502,031 |
| 减:营业外支出 | 529,041.78 | 70,446,789.13 | 11,049,975 | 9,374,825 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 396,825,890.42 | 1,608,918,016.73 | 779,835,153 | 663,181,510 |
| 减:所得税费用 | 35,452,972.69 | 117,228,963.13 | 80,051,223 | 71,238,428 |
| 六、净利润 | 361,372,917.73 | 1,491,689,053.6 | 699,783,930 | 591,943,082 |
| 持续经营净利润 | 361,372,917.73 | 1,491,689,053.6 | 699,783,930 | 591,943,082 |
| 归属于母公司股东的净利润 | 352,721,895.21 | 1,465,476,194.01 | 687,466,463 | 587,027,351 |
| 少数股东损益 | 8,651,022.52 | 26,212,859.59 | 12,317,467 | 4,915,731 |
| (一)基本每股收益 | 0.55 | 2.26 | 1.05 | 0.9 |
| (二)稀释每股收益 | 0.55 | 2.26 | 1.05 | 0.9 |
| 八、其他综合收益 | -5,676,841.42 | -5,904,455.53 | 5,928,165 | 1,116,381 |
| 归属于母公司股东的其他综合收益 | -5,676,841.42 | -5,904,455.53 | 5,928,165 | 1,116,381 |
| 九、综合收益总额 | 355,696,076.31 | 1,485,784,598.07 | 705,712,095 | 593,059,463 |
| 归属于母公司股东的综合收益总额 | 347,045,053.79 | 1,459,571,738.48 | 693,394,628 | 588,143,732 |
| 归属于少数股东的综合收益总额 | 8,651,022.52 | 26,212,859.59 | 12,317,467 | 4,915,731 |
| 公告日期 | 2025-04-29 | 2025-04-24 | 2024-10-29 | 2024-08-29 |
| 审计意见(境内) | | 标准无保留意见 | | |